Cockroaches and rats plaguing NHS hospitals, say staff
Rats and cockroaches are among the pests plaguing NHS hospitals, according to an extensive survey of staff.
NHS workers said rodents and cockroaches, as well as silverfish and other pests, are a regular feature of hospitals and other health service buildings.
The survey of almost 9,000 health workers also revealed problems such as crumbling buildings, sewage leaks, defective lighting and broken toilets.
The research was commissioned by the Unison, the union that represents a range of NHS employees including nurses, paramedics, scientists and cleaners. It suggested the pests were thriving in damp conditions and unfixed buildings.
About one in six of those polled said they had seen vermin such as rats inside their building in the past 12 months. Similarly, 16 per cent said there had been other infestations such as silverfish, ants and cockroaches.
The survey also found that almost one in five staff do not think their building is safe.
More than half of employees reported seeing buckets catching leaking water in their workplace buildings in the past year while 23 per cent witnessed sewage leaks.
Some 28 per cent said public toilets in their hospitals had been out of order for extended periods, while 30 per cent reported broken staff toilets.
Almost half said lifts were out of order, 27 per cent said there was defective lighting and just over one in five warned of ceilings falling apart.
One member of staff working in the North West said rodent bait boxes were dotted all over his hospital and a leaking waste pipe had resulted in a foul odour.
However, rats were still getting into a room storing sterile instruments and supplies, he said.
One hospital staff member from Scotland said ceilings had collapsed and water buckets collecting leaking rainwater were a constant trip hazard.
One building had seen a beetle infestation, and there were regular sewage leaks from broken pipes.
Another worker in charge of cleaning and handling medical equipment in the east of England told Unison he had seen mouse droppings on the floor and desks in reception, in staff break rooms and in the sterile instrument storage room.
Helga Pile, Unison head of health, said: 'This survey paints a worrying picture of an NHS system that's falling apart at the seams and in need of a serious overhaul.
'No one should be dodging rats, stepping over sewage or watching out for falling ceiling tiles in NHS buildings.
'The last thing patients or staff want is vermin, cockroaches and other unpleasant things roaming the wards. Disease-carrying pests can put people's health at risk.
'Previous governments made wildly exaggerated claims about building new hospitals and raided pots of cash earmarked to improve the NHS estate.
'The NHS should be fit for the 21st century, not a crumbling Dickensian relic.
'Fixing the damage done by years of neglect isn't going to be a five-minute job. Money needs to be made available immediately to sort out the worst of the problems.
'Longer-term investment plans must be sped up and maintenance budgets spared the axe.
'If operations are cancelled and wards closed because of pests and sewage leaks, delays and waiting times will only get worse.'
Saffron Cordery, the interim chief executive of NHS Providers, said: 'Safety of patients and staff is the top priority, but this is being put at risk every day from crumbling buildings, pest infestations and sewage leaks.
'It's alarming that NHS trusts have to spend lots of money on pest control on top of a rocketing, near-£14 billion backlog of essential repairs to buildings and equipment which are in a very bad way. Vital parts of the NHS are falling to bits after years of underinvestment nationally.
'Hospitals as well as mental health, community and ambulance services are doing everything they can to improve productivity and deliver more high-quality care, but to do this they need safe, modern, efficient and reliable facilities.
'The condition of the NHS estate is holding them back from doing this as quickly as possible.'
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
ADHD drugs back in the spotlight after study debunks rising prevalence
An increasing number of patients are seeking support for attention-deficit/hyperactivity disorder (ADHD), with pharmacological-based treatments an important part of medical care for the neurodevelopmental condition. A study published this week in the Journal of Affective Disorders has found that greater awareness and acceptance around the disorder has led to more people seeking help. The research, led by a team at King's College, London, debunks claims that the disorder is 'naturally' on the rise. The data comes as a national taskforce in England investigates what this rising demand for support means for the NHS. Figures published in May 2025 by NHS England estimated there were nearly 2.5 million people in England with ADHD. This includes more than 550,000 currently waiting for an assessment. Every month 20,000 more people are referred for support, a rise of 13% compared to last year. Pharmaceutical Technology looks at some of the current options in the UK and casts an eye ahead to what the future drug landscape might contain. The first choice for patients with ADHD is methylphenidate, which belongs to a class of drugs called central nervous system (CNS) stimulants. The drug, which works by blocking the reuptake of norepinephrine and dopamine, increases activity in the brain, including regions associated with attention and behaviour. It is known under the brand names Ritalin, manufactured by Novartis, and Johnson and Johnson's Concerta. There is also Equasym and Xenidate, among others. Lisdexamfetamine dimesylate is also used to treat patients with ADHD. Like methylphenidate, lisdexamfetamine is a CNS stimulant and acts as a norepinephrine and dopamine reuptake inhibitor (NDRI). This drug is known under the brand name, among others, as Elvanse and Vyvanse, both manufactured by Takeda. While stimulants are fast acting, with side effects felt soon after administration, non-stimulant drugs take longer, yet can offer an alternative if drugs like methylphenidate and lisdexamfetamine dimesylate do not work. While improving, access to pharmacological-based treatments is still impaired amid an ongoing global shortage that began in September 2023. Methylphenidate and lisdexamfetamine were primarily affected – the shortage arising due to a combination of manufacturing issues and increased global demand. A separate study published in The American Journal of Managed Care in March suggested that overdiagnosis of ADHD is fuelling the shortage of stimulation medications. One of the most advanced candidate drugs, and one with notable buzz surrounding it, is Axsome's Sunosi (solriamfetol). Sunosi, which is also an NDRI but not a conventional stimulant, met its primary endpoint in a Phase III trial (NCT05972044) earlier this year. The medication led to a 45% drop in ADHD symptoms. As measured by the Adult ADHD Investigator Symptom Rating Scale (AISRS), 150mg Sunosi dosed achieved average reductions from baseline of 17.7 points, compared to 14.3 points for placebo. Sunosi is already approved in the UK to treat excessive daytime sleepiness (EDS) in adults with narcolepsy, with or without cataplexy. Certain patients with obstructive sleep apnoea (OSA) are also eligible to take the medication. In 2022, Axsome paid $53m up front to acquire Sunosi from Jazz Pharmaceuticals. A drug with a recent approval extension in the US, though not the UK, was Supernus Pharmaceuticals' Qelbree (viloxazine extended-release capsules). The mechanism of action of Qelbree, though unclear, is thought to be through inhibiting the reuptake of norepinephrine. Originally approved for children in 2021, the FDA updated the drug's label in January this year to include adults. ADHD treatments were in the political crosshairs in the US recently. The disorder, along with autism, was singled out by the Trump administration for an 'over-utilisation of medication'. Pharmaceutical intervention remains a helpful part of managing the disorder, though it is part of a combination of treatments that also include coaching and lifestyle changes. "ADHD drugs back in the spotlight after study debunks rising prevalence" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Hospitals to get £2.6m for infrastructure upgrades
Several hospitals are set to get upgrades after Nottinghamshire Healthcare NHS Foundation Trust has secured government funding. Work will include improving fire safety systems, water infrastructure and electrical and energy systems at Rampton Hospital, The Wells Road Centre, Wathwood Hospital, Thorneywood Mount and Arnold Lodge Hospital. The improvements at the sites, which offer mental health and community services across the Midlands and South Yorkshire, are due to start in the summer with the aim of completing next spring. Nottinghamshire Healthcare NHS Foundation Trust, which runs the hospitals, said the funding would support urgent projects and create a better environment for patients. The £2,595,000 grant is part of a national project to improve NHS buildings and infrastructure in England. At Rampton High Secure Hospital and several others, it is hoped the money will allow a full upgrade of fire safety systems - including alarms, fire compartmentation and suppression technology. The Wells Road Centre in Mapperley, Nottingham, will benefit from the replacement of ageing machinery. While at Arnold Lodge, in Leicester, a specialist secure unit, the money will deliver electrical and energy system improvements. The trust said planning work was under way to ensure the disruption was minimal. Chief executive at the trust Ifti Majid said the funding was "fantastic news", adding: "It allows us to fast-track improvements that make our hospitals safer, greener and more welcoming places to receive care and to work." Alison Wyld, executive director of finance and estates, added: "By tackling our highest-risk infrastructure now, we're not only reducing future maintenance costs but also supporting the trust's net zero ambitions." Follow BBC Nottingham on Facebook, on X, or on Instagram. Send your story ideas to eastmidsnews@ or via WhatsApp on 0808 100 2210. High-security hospital 'still needs to improve' Work begins on £12m endoscopy unit at city hospital Construction under way on new hospital theatre suite Photos show 'crumbling', abandoned hospital rooms Nottinghamshire Healthcare NHS Foundation Trust
Yahoo
6 hours ago
- Yahoo
New boss confirmed for NHS healthcare trust
A new chief executive has been announced at a health trust where the current boss is stepping down after more than 37 years in the NHS. Surrey and Sussex Healthcare NHS Trust (SASH) said Andrew Hines would take over in the autumn. He currently works at Barts Health NHS Trust in London as executive director for group development. Angela Stevenson, who started her career as a student nurse in Glasgow in 1988, retires in August. Trust chairperson Anita Donley said she was pleased to be announcing Mr Hines as the next chief executive. "I know he will bring energy, commitment and dedication to this role, and his experience will be instrumental in leading the trust forward into the next stage of its journey as an acute provider," she added. Mr Hines said he was delighted and proud to be taking up the role. He added: "The trust provides vital services to a growing population across east Surrey and west Sussex. "I'm looking forward to working with its fantastic staff and building on relationships with partner organisations." The trust was formed in 1998, as a result of a merger between the East Surrey Healthcare NHS Trust and Crawley Horsham NHS Trust. It runs Crawley, Horsham, Caterham Dene and East Surrey hospitals. Follow BBC Surrey on Facebook, on X, and on Instagram. Send your story ideas to southeasttoday@ or WhatsApp us on 08081 002250. Hospital chief retiring after 37 years in NHS Thousands to benefit from new NHS hub Frailty unit cuts down hospital stays for elderly Surrey and Sussex NHS Trust